Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23425819 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
Condition: Severe Sepsis
Interventions: Drug: Talactoferrin alfa;   Drug: Placebo

Indicates status has not been verified in more than two years